Nitrofurantoin

呋喃妥因

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameNitrofurantoin
Drug Alias Name硝呋妥因nitrofurantoinum丹塔呋呋喃咀啶呋喃妥英 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsPainCystitisUrinary Bladder Diseases +[8] 
Global Approved IndicationsPyelitisUrinary Tract InfectionsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1953/02/06
Country/TerritoryCanadaUnited StatesPakistan +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesProcter & Gamble Company
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical CenterMercury Pharmaceuticals LtdUniversity Of Minnesota +[5] 
Inactive CompaniesProcter & Gamble Pharmaceuticals IncMylan Pharmaceuticals IncNovopharm Pharmaceuticals Ltd
Active IndicationsPainCystitisUrinary Bladder Diseases +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01XE01
Related LinksWikipediaDrugBankKEGG